AstraZeneca pulls women’s cancer drug over PBS pricing | 7NEWS

AstraZeneca is withdrawing Zoladex from the Australian market, leaving approximately 8,000 women who rely on the monthly injection to treat breast cancer, endometriosis and other conditions in uncertainty. The pharmaceutical company claims the price paid through the PBS is no longer commercially viable, though it has committed to continue supplying the drug free for patients with no alternative treatment options while negotiations continue for a stronger three-monthly injection. The withdrawal highlights growing tensions between pharmaceutical companies demanding higher prices and the government’s refusal to increase PBS subsidies.

Subscribe and set 🔔 » https://7news.link/YTSubscribe |

For the latest Australian news and breaking news alerts, connect with 7NEWS online:
Visit » https://7news.com.au
7Plus » https://7plus.com.au/
7NEWS Podcast » https://open.spotify.com/user/dm9fk9hzoe68ibpttheragdgi
Facebook » https://www.facebook.com/7NewsAustralia
TikTok » https://www.tiktok.com/@7newsaustralia
Instagram » https://www.instagram.com/7newsaustralia/
X » https://x.com/7NewsAustralia

7NEWS combines the trusted and powerful news brands including Sunrise, The Morning Show, Spotlight and 7NEWS.com.au, delivering unique, engaging and continuous coverage on the issues that matter most to Australians. Watch 7 News Australia full broadcasts and full episodes at 6pm and weekdays at 12pm and 4pm on Channel 7 and 7plus.

#BREAKINGNEWS #7NEWS